Pre-registration for the LinkedIn Live event will begin on Thursday, September 28th Industry experts to discuss the need for non-abstinence-based…
SEBASTIAN, FL / ACCESSWIRE / September 27, 2023 / Addiction Helpline America, a no-cost to consumer drug and alcohol treatment…
$3 million awarded by DoD to University of North Carolina Institute of Trauma Recovery to support a proposed 180-patient, randomized,…
Preliminary Research on Late Life Depression and Accelerated Depression Treatment Protocol will be FeaturedBURLINGTON, Mass. and JERUSALEM, Sept. 27, 2023…
The data hub provides policymakers and advocates with insights into the demographics and history of people seeking treatment to inform…
NEW YORK, NY, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Vice Health and Wellness Inc. (Vice) (CSE: VICE) (OTC Pink: VICFF)…
mTNX-1700 (mTFF2-MSA) suppresses tumor growth and increases survival rates in preclinical colorectal cancer models mTNX-1700 shows single agent activity and…
SEATTLE, WA / ACCESSWIRE / September 20, 2023 / NorthStar Care, a next-generation virtual substance use disorder treatment program rooted…
EU Patent #19846183.2 - A NOVEL BOTANICAL AND TETRAHYDROCANNABINOL ("THC") FORMULATION FOR THE REDUCTION OF CANNABIS-INDUCED NEGATIVE NEUROPSYCHIATRIC SIDE-EFFECTSWe believe…
VANCOUVER, British Columbia, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA)…